科研成果详情

题名Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis
作者
发表日期2022-12
发表期刊MOLECULAR MEDICINE   影响因子和分区
语种英语
原始文献类型Article
关键词Sepsis Intestinal barrier dysfunction CD40L-CD40 Enteric glia cells S-nitrosoglutathione CD40L–CD40
其他关键词NERVOUS-SYSTEM ; CD40 LIGAND ; CELLS ; INJURY ; CONTRIBUTES ; CILOSTAZOL ; RELEASE ; DISEASE ; PROTEIN
摘要Background Intestinal barrier dysfunction, which is associated with reactive enteric glia cells (EGCs), is not only a result of early sepsis but also a cause of multiple organ dysfunction syndrome. Inhibition of platelet activation has been proposed as a potential treatment for septic patients because of its efficacy in ameliorating the organ damage and barrier dysfunction. During platelet activation, CD40L is translocated from alpha granules to the platelet surface, serving as a biomarker of platelet activation a reliable predictor of sepsis prognosis. Given that more than 95% of the circulating CD40L originate from activated platelets, the present study aimed to investigate if inhibiting platelet activation mitigates intestinal barrier dysfunction is associated with suppressing reactive EGCs and its underlying mechanism. Methods Cecal ligation and puncture (CLP) was performed to establish the sepsis model. 24 h after CLP, the proportion of activated platelets, the level of sCD40L, the expression of tight-junction proteins, the intestinal barrier function and histological damage of septic mice were analyzed. In vitro, primary cultured EGCs were stimulated by CD40L and LPS for 24 h and EGCs-conditioned medium were collected for Caco-2 cells treatment. The expression of tight-junction proteins and transepithelial electrical resistance of Caco-2 cell were evaluated. Results In vivo, inhibiting platelet activation with cilostazol mitigated the intestinal barrier dysfunction, increased the expression of ZO-1 and occludin and improved the survival rate of septic mice. The efficacy was associated with reduced CD40L(+) platelets proportion, decreased sCD40L concentration, and suppressed the activation of EGCs. Comparable results were observed upon treatment with compound 6,877,002, a blocker of CD40L-CD40-TRAF6 signaling pathway. Also, S-nitrosoglutathione supplement reduced intestinal damage both in vivo and in vitro. In addition, CD40L increased release of TNF-alpha and IL-1 beta while suppressed the release of S-nitrosoglutathione from EGCs. These EGCs-conditioned medium reduced the expression of ZO-1 and occludin on Caco-2 cells and their transepithelial electrical resistance, which could be reversed by CD40-siRNA and TRAF6-siRNA transfection on EGCs. Conclusions The inhibition of platelet activation is related to the suppression of CD40L-CD40-TRAF6 signaling pathway and the reduction of EGCs activation, which promotes intestinal barrier function and survival in sepsis mice. These results might provide a potential therapeutic strategy and a promising target for sepsis.
资助项目National Natural Science Foundation of China [81801899, 81974540, 81971290]
出版者SPRINGER
出版地NEW YORK
ISSN1076-1551
EISSN1528-3658
卷号28期号:1页码:127
DOI10.1186/s10020-022-00562-w
页数18
WOS类目Biochemistry & Molecular Biology ; Cell Biology ; Medicine, Research & Experimental
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology ; Research & Experimental Medicine
WOS记录号WOS:000885316600003
收录类别SCIE ; SCOPUS ; PUBMED
URL查看原文
Pubmed记录号36401163
Scopus记录号2-s2.0-85142402406
通讯作者地址[Li, Yansong]Xi An Jiao Tong Univ, Dept Anesthesiol, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China. ; [Li, Yansong]Xi An Jiao Tong Univ, Ctr Brain Sci, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China.
scopus学科分类Molecular Medicine;Molecular Biology;Genetics;Genetics (clinical)
引用统计
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/184001
专题附属第一医院_麻醉科
通讯作者Li, Yansong
作者单位
1.Department of Anesthesiology & Center for Brain Science,First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,710061,China;
2.Department of Anesthesiology,First Affiliated Hospital of Wenzhou Medical University,Wenzhou,325000,China
推荐引用方式
GB/T 7714
Cheng, Bo,Du, Mengyu,He, Shuxuan,et al. Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis[J]. MOLECULAR MEDICINE,2022,28(1):127.
APA Cheng, Bo., Du, Mengyu., He, Shuxuan., Yang, Lan., Wang, Xi., ... & Li, Yansong. (2022). Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis. MOLECULAR MEDICINE, 28(1), 127.
MLA Cheng, Bo,et al."Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis".MOLECULAR MEDICINE 28.1(2022):127.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Cheng, Bo]的文章
[Du, Mengyu]的文章
[He, Shuxuan]的文章
百度学术
百度学术中相似的文章
[Cheng, Bo]的文章
[Du, Mengyu]的文章
[He, Shuxuan]的文章
必应学术
必应学术中相似的文章
[Cheng, Bo]的文章
[Du, Mengyu]的文章
[He, Shuxuan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。